| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.62B | 25.15B | 24.17B | 23.93B | 23.50B | 21.88B |
| Gross Profit | 8.97B | 9.16B | 8.77B | 8.28B | 8.31B | 7.33B |
| EBITDA | 3.87B | 3.40B | 3.66B | 3.13B | 3.31B | 2.47B |
| Net Income | 1.87B | 1.86B | 1.71B | 1.36B | 1.46B | 797.00M |
Balance Sheet | ||||||
| Total Assets | 49.91B | 50.22B | 49.90B | 49.35B | 46.51B | 45.27B |
| Cash, Cash Equivalents and Short-Term Investments | 14.04B | 15.38B | 14.21B | 15.45B | 14.30B | 14.32B |
| Total Debt | 330.00M | 0.00 | 330.00M | 330.00M | 390.00M | 430.00M |
| Total Liabilities | 8.28B | 6.82B | 8.39B | 8.93B | 8.14B | 7.75B |
| Stockholders Equity | 41.52B | 43.27B | 41.41B | 40.33B | 38.27B | 37.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.08B | 1.07B | 1.87B | 1.03B | 826.00M |
| Operating Cash Flow | 0.00 | 1.94B | 1.87B | 2.62B | 1.78B | 1.75B |
| Investing Cash Flow | 0.00 | -2.45B | -459.00M | -761.00M | -1.59B | -694.00M |
| Financing Cash Flow | 0.00 | -1.11B | -850.00M | -812.00M | -812.00M | -676.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥45.18B | 8.51 | ― | 3.53% | -7.83% | 13.79% | |
77 Outperform | ¥43.36B | 12.23 | ― | 0.13% | 8.56% | 41.65% | |
74 Outperform | ¥79.40B | 9.90 | ― | 3.06% | 2.53% | 5.98% | |
67 Neutral | ¥103.06B | 13.18 | ― | 3.88% | -8.00% | -7.64% | |
64 Neutral | ¥27.68B | 9.28 | ― | 3.53% | 4.47% | 9.89% | |
63 Neutral | ¥28.56B | 15.39 | ― | 3.45% | 4.08% | 8.34% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |